Boyvadoglu, C. Et Al. 2023. Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria. Mediators of Inflammation , vol.2023 .

Boyvadoglu, C., Ulusal, H., Taysi, S., Özaydın Yavuz, G., Yavuz, İ. H., Korkmaz, P., ... Inaloz, H. S.(2023). Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria. Mediators of Inflammation , vol.2023.

Boyvadoglu, Cagdas Et Al. "Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria," Mediators of Inflammation , vol.2023, 2023

Boyvadoglu, Cagdas Et Al. "Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria." Mediators of Inflammation , vol.2023, 2023

Boyvadoglu, C. Et Al. (2023) . "Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria." Mediators of Inflammation , vol.2023.

@article{article, author={Cagdas Boyvadoglu Et Al. }, title={Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria}, journal={Mediators of Inflammation}, year=2023}